Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
It is a legitimate question for that drug class, but it is a completely different question from ours
Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S (2016) Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and Meta-analysis
This thermoregulatory response appears to be dose-dependent and typically becomes noticeable within the first few training sessions
The use of recombinant growth hormone is associated with insulin resistance
STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis